Worldwide therapeutic licensing and acquisition deals share 2009-2018 by disease type

In the period 2009-2018, licensing and acquisition deals concerning oncology accounted for 29 percent of all therapeutic company licensing deals. This graph shows the share of total licensing and acquisition deals of therapeutic companies worldwide for the period from 2009 to 2018, by disease type.

Share of licensing and acquisition deals of therapeutic companies worldwide between 2009 and 2018, by disease

Licensing*Acquisition**
Oncology29%28%
Platform8%13%
Infectious Disease10%11%
Neurology12%11%
Immunology8%6%
Endocrine6%5%
Metabolic4%4%
Cardiovascular4%4%
Respiratory2%3%
Ophthamology3%3%
Hematology3%2%
Gastrointestinal3%2%
Psychiatry2%1%
Other diseases8%6%
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

2019

Region

Worldwide

Survey time period

2009 to 2018

Supplementary notes

* Only R&D stage therapeutics from emerging companies.
** Only acquisitions of R&D stage therapeutic companies.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Diabetes in the United Kingdom (UK)"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.